These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35150849)

  • 1. Cardiovascular magnetic resonance imaging in myocardial involvement of systemic lupus erythematosus.
    Luo S; Dou WQ; Schoepf UJ; Varga-Szemes A; Pridgen WT; Zhang LJ
    Trends Cardiovasc Med; 2023 Aug; 33(6):346-354. PubMed ID: 35150849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular magnetic resonance evaluation of paediatric patients with systemic lupus erythematosus and cardiac symptoms.
    Mavrogeni S; Smerla R; Grigoriadou G; Servos G; Koutsogeorgopoulou L; Karabela G; Stavropoulos E; Spiliotis G; Kolovou G; Papadopoulos G
    Lupus; 2016 Mar; 25(3):289-95. PubMed ID: 26453663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial injury in systemic lupus erythematosus according to cardiac magnetic resonance tissue characterization: clinical and echocardiographic features.
    du Toit R; Herbst PG; Ackerman C; Pecoraro AJ; du Toit RH; Hassan K; Joubert LH; Reuter H; Doubell AF
    Lupus; 2020 Oct; 29(11):1461-1468. PubMed ID: 32631204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus.
    Mavrogeni S; Koutsogeorgopoulou L; Markousis-Mavrogenis G; Bounas A; Tektonidou M; Lliossis SC; Daoussis D; Plastiras S; Karabela G; Stavropoulos E; Katsifis G; Vartela V; Kolovou G
    Lupus; 2018 Apr; 27(4):564-571. PubMed ID: 28927316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis.
    Mavrogeni S; Bratis K; Markussis V; Spargias C; Papadopoulou E; Papamentzelopoulos S; Constadoulakis P; Matsoukas E; Kyrou L; Kolovou G
    Lupus; 2013 Jan; 22(1):34-43. PubMed ID: 23035042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus.
    Winau L; Hinojar Baydes R; Braner A; Drott U; Burkhardt H; Sangle S; D'Cruz DP; Carr-White G; Marber M; Schnoes K; Arendt C; Klingel K; Vogl TJ; Zeiher AM; Nagel E; Puntmann VO
    Ann Rheum Dis; 2018 Nov; 77(11):1590-1598. PubMed ID: 30077990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Native T1 and T2 mapping by CMR in lupus myocarditis: Disease recognition and response to treatment.
    Hinojar R; Foote L; Sangle S; Marber M; Mayr M; Carr-White G; D'Cruz D; Nagel E; Puntmann VO
    Int J Cardiol; 2016 Nov; 222():717-726. PubMed ID: 27521546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac involvement in ANCA (+) and ANCA (-) Churg-Strauss syndrome evaluated by cardiovascular magnetic resonance.
    Mavrogeni S; Karabela G; Gialafos E; Stavropoulos E; Spiliotis G; Katsifis G; Kolovou G
    Inflamm Allergy Drug Targets; 2013 Oct; 12(5):322-7. PubMed ID: 23909889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of clinical and subclinical myocardial injury in systemic lupus erythematosus - A prospective cohort study.
    du Toit R; Herbst PG; Ackerman C; Pecoraro AJ; Claassen D; Cyster HP; Reuter H; Doubell AF
    Lupus; 2021 Feb; 30(2):256-268. PubMed ID: 33525979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography.
    Burkard T; Trendelenburg M; Daikeler T; Hess C; Bremerich J; Haaf P; Buser P; Zellweger MJ
    PLoS One; 2018; 13(10):e0202105. PubMed ID: 30273933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The apparent diffusion coefficient is strongly correlated with extracellular volume, a measure of myocardial fibrosis, and subclinical cardiomyopathy in patients with systemic lupus erythematosus.
    Wu R; An DA; Hu J; Jiang M; Guo Q; Xu JR; Wu LM
    Acta Radiol; 2018 Mar; 59(3):287-295. PubMed ID: 28679323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus.
    Puntmann VO; D'Cruz D; Smith Z; Pastor A; Choong P; Voigt T; Carr-White G; Sangle S; Schaeffter T; Nagel E
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):295-301. PubMed ID: 23403334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Magnetic Resonance Imaging T1 and T2 Mapping in Systemic Lupus Erythematosus in Relation to Antimalarial Treatment.
    Shalmon T; Thavendiranathan P; Seidman MA; Wald RM; Karur GR; Harvey PJ; Akhtari S; Osuntokun T; Tselios K; Gladman DD; Hanneman K
    J Thorac Imaging; 2023 May; 38(3):W33-W42. PubMed ID: 36917505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach.
    Abdel-Aty H; Siegle N; Natusch A; Gromnica-Ihle E; Wassmuth R; Dietz R; Schulz-Menger J
    Lupus; 2008 Jun; 17(6):561-7. PubMed ID: 18539710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of Q waves in II, III, avF in systemic lupus erythematosus. Evaluation using cardiovascular magnetic resonance imaging.
    Mavrogeni S; Bratis K; Kolovou G
    Lupus; 2012 Jul; 21(8):821-9. PubMed ID: 22422802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus.
    Zhang Y; Corona-Villalobos CP; Kiani AN; Eng J; Kamel IR; Zimmerman SL; Petri M
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):389-97. PubMed ID: 25352245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial inflammation in autoimmune diseases: investigation by cardiovascular magnetic resonance and endomyocardial biopsy.
    Mavrogeni S; Spargias K; Markussis V; Kolovou G; Demerouti E; Papadopoulou E; Stavridis G; Kaklamanis L; Douskou M; Constantoulakis P; Cokkinos DV
    Inflamm Allergy Drug Targets; 2009 Dec; 8(5):390-7. PubMed ID: 20025587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Detection of Silent Myocardial Impairment in Drug-Naive Patients With New-Onset Systemic Lupus Erythematosus: A Three-Center Prospective Study.
    Guo Q; Wu LM; Wang Z; Shen JY; Su X; Wang CQ; Gong XR; Yan QR; He Q; Zhang W; Xu JR; Jiang M; Pu J
    Arthritis Rheumatol; 2018 Dec; 70(12):2014-2024. PubMed ID: 30070061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial involvement in systemic lupus erythematosus detected by magnetic resonance imaging.
    Been M; Thomson BJ; Smith MA; Ridgway JP; Douglas RH; Been M; Best JJ; Muir AL
    Eur Heart J; 1988 Nov; 9(11):1250-6. PubMed ID: 3234418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report.
    Singh JA; Woodard PK; Dávila-Román VG; Waggoner AD; Gutierrez FR; Zheng J; Eisen SA
    Lupus; 2005; 14(2):137-44. PubMed ID: 15751818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.